Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders
The trajectory of semaglutide exemplifies how intentional peptide design, iterative translational research, and outcome-driven clinical trial design can lead to groundbreaking therapies for complex metabolic disorders.
Authors
- Ralf Weiskirchen (ORCID: https://orcid.org/0000-0003-3888-0931)
- Amedeo Lonardo (ORCID: https://orcid.org/0000-0001-9886-0698)
Institutions
- Azienda Unita' Sanitaria Locale Di Modena (IT)
- Universitätsklinikum Aachen (DE)
- RWTH Aachen University (DE)
Publication Details
- Journal
- Medical Sciences
- Published
- 2025-11-12
- DOI
- https://doi.org/10.3390/medsci13040265
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00